STRATEGIC APPROACH & WORKPLAN 2007
|
|
- Deirdre Leona Goodwin
- 5 years ago
- Views:
Transcription
1 Rare Diseases Europe STRATEGIC APPROACH & WORKPLAN 2007 Paris, March
2 Contents Our strategic approach o Eurordis in 2010 o Strategic orientations o Priorities Our action plan 2007 o Key priorities o Key topics Budget 2007 Significant European activities Eurordis Workplan
3 Our Strategic Approach Eurordis in 2010 Eurordis is the European movement of rare disease patient groups and individuals and their European voice. Eurordis bring added value through advocacy, information, capacity building and services Eurordis added value is perceived by our members, patients & families and stakeholders Eurordis has a renewed long term vision and strategy. Strategic orientations Fewer priorities to achieve measurable results More innovative therapies, patient-centred healthcare and patient driven research bridging science & society More integrated approach between EU and national levels, and between Eurordis and national alliances Based more deeply on individual patient and families Develop private funding for resource diversification and for long term financial self-sustainability Promote Eurordis as a brand name in everything we do Web Communications at the centre of what we do: members, volunteers, staff, patient and families as producers of information More international openness and perspective Build a long term and prospective vision Eurordis Workplan
4 Priorities Rare Diseases: a priority visible on the European agenda Promote rare diseases public health policies at EU and national levels Focus on key advocacy issues Web communications for everything we do Annual European rare disease awareness campaign 2008 & 2009 A broader grassroots patient-centred community Centre our action on our members Reinforce our patient group membership base Special focus on new and future Member States Develop individual membership Involve more volunteers in our activities Organise capacity building and training sessions for patient representatives Better structure our network (new national alliances, European network of national alliances, European specific disease networks, country liaison officers) Budget growth and funding diversification Increase EU support to Eurordis projects and other rare disease activities Reinforce current funding base: AFM, members, health industry Develop private funding and partnerships with corporations and foundations outside the health sector Develop individual support and fund raising events Consolidation of two major events Membership meeting 200X City (annual) European Rare Disease Conference 200X City (every other year) Shaping the Rare Disease European Environment Shifting our priorities toward more public health activities and services to patients and families: o Access to quality care and European networks: Centres of Expertise and European Reference network Patient mobility Good practices diagnosis, gene testing, counseling, screening Good practices based on consensus medical care o Access to quality services and European networks: Help Lines Isolated patients Web patient communities Therapeutic Recreation Programmes Integration at School Respite Care Services Activities on therapy development focused on: o Orphan drugs: speed up development and availability o Advanced therapies: gene therapy, cell therapy o Inform more and involve more members and volunteers Eurordis Workplan
5 Patient driven European research infrastructures addressing bottlenecks toward therapies : o Priority on biobanks o Priority on patient registries o Priorities on clinical trials Bridge the gap between patient needs and research in biomedicine, public health, social, economy, policy and ethic Cross-cutting Priority Develop office support services for better quality work, increased efficiency and better quality at work for all: o Contact Management Database o Advanced Financial Information System o Advanced Human Resource Policy o Advanced Information Technology as a support for projects management, work with volunteers and virtual office to ease mobility o Optimise synergies between websites, project databases, contact management database o Synergy between Eurordis and national alliances o New office support and environment Eurordis Workplan
6 Our action plan 2007 Key priorities Commission s Communication & Council Recommendations Centres of Expertise & European reference networks Future Regulation on Advanced Therapies Implementation of the new Regulation on Paediatric Drugs European Conference on Rare Diseases 2007 Lisbon Networks of services for patients and families of patients Membership Meeting 2007 Paris and capacity building in research for rare disease patient groups Consolidation of activities on orphan drugs 1 or 2 new EC projects: patient group capacity building in science; cooperation and exchange of best practices between patient groups; EuroBioBank II; e-health Strategy and plan for private funding (1st step) Strategy and plan for volunteers (1st step) Eurordis Workplan
7 Key Topics Advocacy Level 1 priorities Commission s Communication and Recommendations to the Council and European Parliament on Rare Diseases ( ) Rare Diseases as a Public Health Priority in Commission programmes and in Member states: o EU Research Framework: promote rare diseases in FP 7 ( )+ input in call for proposal + consensus panels o EU Public Health: promote rare diseases in Work Programme ( ) + input in call for proposals + Rare Disease Task Force o ECRD 2007 Lisbon under Portugal s EU Presidency o Sustainability: propose stronger cooperation between Member States with creation of EU High Level Group on Rare Diseases Centres of Reference and European Reference Networks Patient mobility (part of Services of general interest) Patient access to diagnosis: delay and conditions, proposals to improve earlier diagnosis Orphan Drugs: o Common needs, global development: harmonisation EU/US for designation and parallel procedure toward converging EU/US requirements (joint position paper with NORD) (+ COMP WGIP) o Patient access to authorised orphan drugs in the EU: common policy and criteria for health technology assessment and for pricing and reimbursement (position paper) (+ EMEA COMP) Paediatric Drugs: implementation of EU Regulation + appointment to Paediatric Committee at the EMEA Advanced Therapies: support the future EU Regulation Transparency of NGOs Internationalisation in Rare Diseases Advocacy Level 2 priorities Patient databases, registries and cohorts: promote policy recommendations Rare Disease Biological Resource Banks and European Network: promote policy recommendations and the Charter Clinical Trial Directive: assessment of the impact of the implementation of the Directive on rare disease clinical research in Europe (toward legislative process for revision of the Directive in 2008/10) Orphan Drugs: clinical research grant programmes, unmet medical needs (toward 2008/9 level 1 priority through COMP WGIP) Diseases are rare, patients are many : a quantitative analysis of rare disease numbers Comprehensive approach to rare diseases (beyond medical care) Organ Donation and Transplant for rare disease patients Members and patient groups Membership Meeting 2007 Paris May 3-5 Increase interaction and recognition: favour direct contacts; send more information; ask for opinion; call for volunteers; involve people in projects, workshops, conferences; training sessions Eurordis Workplan
8 Priority recruitment of European Federations and EU Enlargement to new and future Member States 2 European Workshops of National Alliances (Paris May 3 & Lisbon November 26) 20 European Workshops of Rare Disease specific networks (Paris May 3 & Lisbon November 26) Country visits and support: Czech Republic, Greece, Norway, Poland, Portugal, Romania, Health policy: Rare Disease Patient Solidarity Project Centres of Reference and European Network: solid recommendations New Services for patients: towards tangible & measurable outcomes o European network of helplines o Isolated patients o Therapeutic recreational programmes o Respite care services o Internet Patient Communities European Conference on Rare Diseases 2007 Lisbon Therapeutic development Orphan drugs: improve follow up of COMP, Protocol Assistance, marketing authorisations, product information, availability to patients Advocate on orphan drugs in EU/US and on better patient access to drugs Drug Information and Transparency: EMEA PCWP Paediatric Committee ready for implementation Implementation of the Charter on Clinical Trials ERTC Workshops o Availability of Orphan Medicines in Europe o Level of evidence for Proof of concept studies Establish Eurordis Task Forces on: o Drug Information, Transparency and Access Re-establish Eurordis Task Forces on: o Orphan drugs o Paediatric Drugs DIA EuroMeeting Vienna March 2007: o Track for patients o Tutorial o Fellowship programme Capacity building sessions in clinical trials (CAPOIRA project): o Common pedagogic tool and evaluation o Sessions in Denmark, Spain and Italy Research European Workshop «Gaining Access to Rare Disease Research Resources» 3 and 4 May 2007, Paris Establish a Eurordis Research Task Force, composed of volunteers Develop priorities for FP 7 and develop concept of European Agency for Rare Diseases Develop two patient driven pilot health research projects for FP 7 ( ) o Capacity building in research II o EuroBioBank II or e-health Eurordis Workplan
9 Communication and development New EC DG Sanco Project for Website V3 finalised Print-base communication material Celebrating 10 years of Achievements (Eurordis 10 year anniversary) Prepare 2008: o Rare Disease Awareness Campaign 2008 o Develop short & long term fund raising strategy for unrestricted funds Finance and office support Budget reporting and forecast cash flow Support budgeting project development Quality processes: written procedures Volunteer policy Contact management database New offices Eurordis Workplan
10 Budget 2007 * Individual and corporate donations Revenue 2007 = euros Expenses 2007 = euros
11 Eurordis 2007 budget compared to 2006 accounts REVENUE Difference Patient Organisations AFM Membership fees and Grants Volunteers European Commission National authorities Industry and Foundations Industry Foundations and NPOs MIscellaneous EXTraordinary incomes PARtners OTHers Sub-total (I) Report of non-used income TOTAL REVENUE EXPENSES Difference Staff Volunteers Travel and subsistence Services Honorary EC project's partners Telecom and post Rent Others Purchase Miscellaneous Extraordinary expenses Partners Others Sub-total (I) Commitment on assigned income TOTAL EXPENSES PROFIT OR LOSS
12 Significant European activities Eurordis Workplan EURORDIS Plateforme Maladies Rares 102 rue Didot Paris France Tel Fax Brussels office: Tel/fax eurordis@eurordis.org
Table Of Content. EURORDIS_FY Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7
Table Of Content EURORDIS_FY2010... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter and V.3 of EURORDIS website (EN)... 7 D01 - Activity Report OPERA
More informationPHOTO. VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe
www.eurordis.org VHPB/ELPA MEETING Prevention and Control of Viral Hepatitis The role and impact of patients and advocacy groups in and outside Europe Lucca ( Italy ) March 13-14, 2008 PHOTO www.eurordis.org
More informationNORDIC CONFERENCE ON RARE DISEASES
www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases
More informationTable Of Content. European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs...
Table Of Content European Organisation for Rare Diseases... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 D04 - Electronic Newsletter (EN)... 7 D01 - Activity Report EURORDIS
More informationDRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016
DRAFT STRATEGIC APPROACH & ACTION PLAN 2016-2018 For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016 STRATEGIC PRIORITIES 1. Build a legitimate Global RD Patient Alliance to be the
More informationTable Of Content. Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners...
Table Of Content Policy Action and Information for Rare Diseases in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Kontaktudvalget for Mindre Sygdoms-og handicapforeninger (KMS)...
More informationEPAG UPDATE. Lenja Wiehe. European Patient Advocacy Groups Manager, EURORDIS
EPAG UPDATE Lenja Wiehe European Patient Advocacy Groups Manager, EURORDIS Patient Centre & Empowerment European Reference Networks (ERNs) created on founding principles of patient-centred care, patient
More informationthe patients perspective and role of epags
Patients Registry in ERNs: the patients perspective and role of epags 5th International Summer School Rare Disease & Orphan Drug Registries VirginieBros-Facer, Research Infrastructure Project Manager 18
More informationDRAFT STRATEGIC APPROACH & ACTION PLAN For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016
DRAFT STRATEGIC APPROACH & ACTION PLAN 2016-2018 For consultation at RDI Annual Meeting Edinburgh, Scotland May 25, 2016 STRATEGIC PRIORITIES 1. Build a legi4mate Global RD Pa4ent Alliance to be the Voice
More informationThe basics a. Mission Statement (unchanged) eurordi s.org
The basics a. Mission Statement (unchanged) To build a strong pan-european community of patient organisations and people living with rare diseases, To be their voice at the European level And directly
More informationEuropean organisation for rare diseases. Activity Report. Paris, March
European organisation for rare diseases Activity Report > 2009 Paris, March 2010 www.eurordis.org European organisation for rare diseases 11 Health Policy & Health Care Services 7Advocacy 14 Research,
More informationRD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS
RD-ACTION DISSEMINATION PLAN TABLE I - STAKEHOLDER ANALYSIS Stakeholder Group Interest in RD-Action Dissemination purpose Channels of Dissemination (WHO) (WHY) (WHY) (HOW) Partners of RD-Action & members
More informationPogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International Advisory Board
Start by doing what's necessary then do what's possible and suddenly you are doing the impossible Saint Francis of Assisi Pogány Gábor Ph.D. President of HUFERDIS Member of EUCERD and Orphanet International
More informationJoint Programming in Neurodegenerative Disease Research (JPND)
Joint Programming in Neurodegenerative Disease Research (JPND) Building Alliances and Collaborations Prof. Philippe Amouyel, MD, PhD JPND Chair France Disclosure CEO of Fondation Plan Alzheimer Conference
More informationPain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki
Pain and Palliative care in the European Commission s Framework Programmes European Commission Research DG Dr. Elengo Manoussaki European Parliament resolution on combating cancer in the enlarged EU Calls
More information7 th European Conference on Rare Diseases & Orphan Products (ECRD 2014 Berlin) The Rare Disease Puzzle: Bringing the Picture to Life
Save the Date! 8 10 May 2014 Andel s Hotel, Berlin, Germany 2014 Berlin Brussels 23-25 May 2012 7 th European Conference on Rare Diseases & Orphan Products (ECRD 2014 Berlin) The Rare Disease Puzzle: Bringing
More informationEU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014
EU Funding for Global Health Research and Development (GH R&D) Cecile Vernant, Head of EU Advocacy, DSW EU 13 June 2014 EU Horizon 2020 for 2014-2020 In current prices nearly 80 billion; in constant prices
More informationEURORDIS contribution to the Public Consultation Recast of the Medical Devices Directives
EURORDIS contribution to the Public Consultation Recast of the Medical Devices Directives EURORDIS - the European Organisation for Rare Diseases represents 341 rare disease organisations from 38 different
More informationPfizer Support to European and International Patient Organisations in 2008
Pfizer Support to European and International Patient Organisations in 2008 The EFPIA Code on Relationships between the Pharmaceutical Industry and Patient Organisations came into force across Europe on
More informationTable Of Content. Annex 1: Conference report... 7 Annual project reports (URL)... 7 Original Full Information (Dec 2008)... 7.
Table Of Content Alcohol Policy Network in the Context of a Larger Europe: Bridging the Gap... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Outputs... 7 Annex 1: Conference report... 7
More informationTransparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October
Transparency in drug regulatory decision making Why transparency? Birthe Byskov Holm, Rare Diseases Denmark Copenhagen October 2. 2017. Transparency - A tool to drive change and innovasion? Breaking the
More informationTABLE of Contents. EURORDIS in brief
TABLE of Contents 02 Foreword 06 EURORDIS in brief 07 Strategic approach 2015-2020 09 Activity Report 2017 HIGHLIGHTS 2017...11 PATIENT ADVOCACY...12 PATIENT EMPOWERMENT: BUILDING THE NETWORK & CAPACITIES..27
More informationrare diseases research through National Plans and Strategies
Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute
More informationRetina International General Assembly Auckland, New Zealand
Retina International General Assembly 2018 - Auckland, New Zealand Thursday, February 8th, 2018 Location: University of Auckland Business School Owen G Glenn Building, 12 Grafton Road, Auckland, 1010 Room:
More informationEUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)
EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs) EUROPEAN REFERENCE NETWORKS FOR RARE DISEASES IN EUROPE: THE CONTEXT The need for European Reference Networks (ERNs) for rare
More informationThe Life Course Immunisation Initiative
Contents Case Study... 1 Action Proposed... 3 Methodology... 4 Results... 9 Conclusions... 10 Case Study Background Anyone can contract meningitis and septicaemia, therefore everyone has the right to access
More informationPrevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008
Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact
More information10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,
10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan, 2006 2015 Introduction A significant scaling-up of advocacy, communication and social mobilization for TB will
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation),
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationThe Paediatric Regulation a perspective from the European Medicines Agency
The Paediatric Regulation a perspective from the European Medicines Agency Dr Edith La Mache EMEA Current paediatric situation 20% of the EU population, i.e. 100 million, is aged less than 16 years premature
More informationACTION PLAN Adoption Annual Activity & Financial Report 2018 Adoption Work Programme: Action Plan & Budget 2019
ACTION PLAN 2019 1. STRENGTHEN RDI AS A WELL-GOVERNED AND SUSTAINABLE ORGANISATION Governance Legal incorporation in France, as Association Loi 1901, as an NGO, official publication based on Statutes Council
More informationHealth and. Consumers
www.openprogram.eu EU action on obesity Obesity Prevention through European Network Closing event Amsterdam 25 November 2016 Attila Balogh Health determinants and inequalities European Commission Directorate-General
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE
More informationParis, March 2011 European organisation for rare diseases. credit photo Boland. Activity Report.
Paris, March 2011 European organisation for rare diseases credit photo : @Luc Boland Activity Report > WORK PROGRAMME 2011 www.eurordis.org European organisation for rare diseases The Voice of Rare Disease
More informationVision. Mission. Hopelink s Values. Introduction. A community free of poverty
Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential
More informationWorld Hepatitis Alliance Strategic Plan 2015
World Hepatitis Alliance Strategic Plan 2015 Overview Foreword The World Hepatitis Alliance is a notfor-profit international umbrella Non- Governmental Organisation (NGO). Our membership is composed of
More informationEUROPLAN National Conferences and Post-NCs activities in support to Member States
EUROPLAN National Conferences and Post-NCs activities in support to Member States Yann Le Cam, Ariane Weinman, Valentina Bottarelli EURORDIS Team Paris, France Brussels, Belgium EUROPLAN B Domenica Taruscio,
More informationUpdates from the European Centre for Disease Prevention and Control
Updates from the European Centre for Disease Prevention and Control AIRA 2018 National Meeting, Salt Lake City Global Perspectives Plenary session Tarik Derrough Senior Expert Vaccine Preventable Diseases
More informationPerspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
More informationWe are here for our fellow patients
We are here for our fellow patients André Deschamps Boardmember EUOMO November 22, 2017 The European Prostate Cancer Coalition I am a prostate cancer survivor since 2003 Some facts on Europa Uomo The change
More informationJPI A healthy diet for a healthy life. JPI: concept and benefits Vision Research areas Governance
JPI A healthy diet for a healthy life JPI: concept and benefits Vision Research areas Governance European research area Today, 85% of public R&D is programmed, financed, monitored and evaluated at national
More informationInternational Kidney Cancer Coalition. Patient Organisations Working Together Globally to Support Those Affected by Kidney Cancer
International Kidney Cancer Coalition Patient Organisations Working Together Globally to Support Those Affected by Kidney Cancer 2 Our Global Network The IKCC (International Kidney Cancer Coalition) is
More informationKey Highlights continued
Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from the G8, European Commission and Other Donor Governments in 2009 Authors: Jennifer Kates (Kaiser Family
More informationAuthors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).
Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments, 2006 Authors: Jennifer Kates (Kaiser Family Foundation),
More informationEuropean organisation for rare diseases. Activity Report & WORKPLAN The Voice of Rare Disease Patients in Europe. eurordis.
European organisation for rare diseases Activity Report 2012 & WORKPLAN 2013 The Voice of Rare Disease Patients in Europe eurordis.org European 0rganisation for Rare Diseases Activity Report 2012 & WORKPLAN
More informationSTRATEGIC PLAN 2014 to 2017
STRATEGIC PLAN 2014 to 2017 September 2014 1 P a g e KHNZ s STRATEGIC PLAN Contents Page 1. Introduction to the Strategic Plan 3 2. About Kidney Health New Zealand 4 3. The Challenges 6 4. Strategic Context
More informationAlcohol Prevention Day
Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in
More informationOperation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5
Table Of Content Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5 A.N.P.AS. Associazione Nazionale Pubbliche Assistenze... 5
More informationEurordis Membership Meeting 2008 Copenhagen May 2008
Draft Programme Eurordis Membership Meeting 2008 Copenhagen 16-17 May 2008 Quality Hotel Hoje Taastrup Carl Gustavs Gade 1 DK-2630 Taastrup Hosted by Rare Disorders Denmark Acting together for patient-centred
More informationEuropean Organisation for Rare Diseases EURORDIS Rare Diseases Europe
Yann LE CAM PERSONAL INFORMATION Work address: EURORDIS - 96 Rue Didot - 75014 Paris - France & EURORDIS University Foundation 11 rue d Egmont - 1000 Brussels - Belgium Telephone: +33 1 56 53 52 11 E-mail:
More informationR&D Status in Romania
R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;
More informationFundraising in a patient organization
Fundraising in a patient organization what are your dreams? what is your vision? what are your goals? what do you need to get there? Fundraising in a patient organization is it a priority on your agenda?
More informationInduction training for national partners in Brussels
Induction training for national partners in Brussels Country of the month Macedonia News from the EC meeting Training design team meeting in Budapest Newsletter February 2015 Icons from freepik.com Reinhard
More informationEurasian Harm Reduction Association (EHRA) Strategic Framework
Eurasian Harm Reduction Association (EHRA) Strategic Framework 2018-2019 What is Eurasian Harm Reduction Association (EHRA)? 2 How does strategic framework work? 2 Harm reduction, current context 3 EHRA
More informationThe mission of AIGA is to advance designing as a professional craft, strategic tool and vital cultural force. Mission statement
How AIGA is organized AIGA is a nonprofit professional membership organization founded in 1914, incorporated in the state of New York and headquartered in New York City. It is a volunteer membership organization
More informationGLP in the European Union Ecolabel detergents, GLP and accreditation
GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European
More informationDeliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society
Deliverable Grant Agreement number: 611742 Project acronym: PASTEUR4OA Project title: Open Access Policy Alignment STrategies for European Union Research Funding Scheme: FP7 CAPACITIES Science in Society
More informationCancer Research in the EU Framework Programmes for RTD
Cancer Research in the EU Framework Programmes for RTD Action against cancer: European platform Maria Vidal, MD, PhD Deputy Head of Unit Medical and public health research Health Directorate DG Research
More informationUK Guidance on Sexual Assault Interventions. Recommendations to improve the standards of policy and practice in the UK
UK Guidance on Sexual Assault Interventions Recommendations to improve the standards of policy and practice in the UK UK Guidance on Sexual Assault Interventions Recommendations to improve the standards
More informationThe Maltese Presidency of the Council of the EU Veterinary Sector
The Maltese Presidency of the Council of the EU Veterinary Sector 1 January 30 June 2017 Presidency Priority Antimicrobial resistance Global Action Plan on AMR One Health approach addressing the threat
More informationPriority Medicines for Europe and the World: Setting a public health based medicines development agenda
Priority Medicines for Europe and the World: Setting a public health based medicines development agenda Warren Kaplan, Veronika Wirtz (BU School of Public Health) Aukje Mantel, Pieter Stolk (UU) Béatrice
More informationGUATEMALA S FAMILY PLANNING TRANSITION Successes, Challenges, and Lessons Learned for Transitioning Countries
GUATEMALA S FAMILY PLANNING TRANSITION Successes, Challenges, and Lessons Learned for Transitioning Countries ATTAINING SUSTAINABLE FINANCING FOR FAMILY PLANNING IN SUB-SAHARAN AFRICA ACCRA, JANUARY 2018
More informationPosition Description Ovarian Cancer Australia Support Coordinator, Support Programs
Position Description Ovarian Cancer Australia Support, Position Purpose The Support, is one of three roles responsible for the further development, coordination and implementation of Ovarian Cancer Australia
More informationEFSA and Member States
Scientific Cooperation between EFSA and Member States Taking Stock and Looking Ahead Committed to ensuring that Europe s food is safe Scientific Cooperation between EFSA and Member States Scientific cooperation
More informationA Blueprint for Breast Cancer Deadline 2020
A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing
More informationTREAT-NMD Neuromuscular Network
TREAT-NMD Neuromuscular Network 16 th November 2007 Newsletter No. 21 Welcome to the latest newsletter from the TREAT-NMD network. This edition features a meeting report from last week s patient registry
More informationPfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016
Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016 Please note that all information in this document is also disclosed in the overall report on Pfizer
More informationState of the Art of Rare Disease - Activities in EU Member States and Other European Countries. Belgium Report
State of the Art of Rare Disease - Activities in EU Member States and Other European Countries Definition of a Rare Disease Belgium Report The definition of rare diseases in the Belgian Plan for Rare Diseases
More informationDIRECTORATE GENERAL FOR INTERNAL POLICIES GENDER EQUALITY
DIRECTORATE GENERAL FOR INTERNAL POLICIES GENDER EQUALITY The situation of women living in rural areas of the European Union Presentation by Ramona Franić University of Zagreb, Faculty of Agriculture ramonaf@agr.hr
More informationUseful EU information on organ donation and transplantation
Useful EU information on organ donation and transplantation 1) EU funded and co-funded Projects European Training Program on Organ Donation - EPTOD The aim of this project is to design a professional European
More informationOn 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.
COUNCIL OF THE EUROPEAN UNION Brussels, 24 May 2005 9278/05 DEVGEN 92 RELEX 257 SAN 74 ONU 61 ACP 73 NOTE from : General Secretariat dated 24 May 2005 No. prev. doc. : 9085/05 DEVGEN 88 RELEX 238 SAN 62
More informationRESPECT Project CASE STUDY
CASE STUDY RESPECT Project RESPECT aims to provide vulnerable and disadvantaged families with support that will promote positive relationships and a stable family structure through regular and consistent
More informationThe European Neighbourhood Policy (ENP) ENP Coordination External Relations Directorate General European Commission
The European Neighbourhood Policy (ENP) ENP Coordination External Relations Directorate General European Commission Different neighbours, different relations EFTA / EEA Candidate Countries (Croatia, former
More informationInternational Bureau for Epilepsy MEMBERSHIP GUIDE Benefits and Responsibilities
MEMBERSHIP GUIDE Benefits and Responsibilities IBE is an international umbrella network organisation comprised of more than 130 national epilepsy patient education and advocacy associations worldwide www.ibe-epilepsy.org
More informationAn introduction to the Alliance for Maternal Health Equality
An introduction to the Alliance for Maternal Health Equality Euro-Peristat Meeting 5 April 2016 Jacqueline Bowman-Busato Policy Lead Alliance for Maternal health Equality 1 Challenge Maternal and perinatal
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 20.10.2009 COM(2009) 567 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND
More informationBDA IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS NOVEMBER 2013 WORKSHOP ADVANCE PROGRAMME
BDA WORKSHOP IMPROVING ONCOLOGY DRUG DEVELOPMENT FOR CHILDREN AND ADOLESCENTS 18-19 NOVEMBER 2013 PARIS, FRANCE BIOTHERAPY DEVELOPMENT ASSOCIATION encca European Network for Cancer Research in Children
More informationThe Republic of Macedonia on its way to the EU Building up of the food safety system in cooperation with EFSA
The Republic of Macedonia on its way to the EU Building up of the food safety system in cooperation with EFSA Dushica Santa, Assistant coordinator and Macedonia Focal point for EFSA 9th Scientific Conference
More informationREPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS
More informationNew Horizons for Vaccine R&D&I in Europe
New Horizons for Vaccine R&D&I in Europe Health, Demographic Change and Wellbeing Ruxandra Draghia-Akli MD, PhD Directorate E - Health Research DG - Research & Innovation European Commission Why EU support
More informationMRCG Strategic Document
MRCG Strategic Document 2015-2016 The Medical Research Charities Group (MRCG) is an umbrella group of medical research and patient support charities that seeks to generate dynamic medical research in Ireland,
More informationMHE Position on the EC Green Paper on Mental Health An EU Strategy on Mental Health and Well Being
MHE Position on the EC Green Paper on Mental Health An EU Strategy on Mental Health and Well Being MENTAL HEALTH EUROPE SANTE MENTALE EUROPE aisbl Boulevard Clovis 7, B-1000 Brussels Tel +32 2 280 04 68
More informationEurasian Harm Reduction Association (EHRA) Strategic Framework
Eurasian Harm Reduction Association (EHRA) Strategic Framework 2018-2019 What is the Eurasian Harm Reduction Association (EHRA)? 2 The mission, vision and role of EHRA 2 The current context of harm reduction
More informationAddis Ababa, ETHIOPIA P. O. Box 3243 Telephone Cables: OAU, ADDIS ABABA
AFRICAN UNION UNION AFRICAINE UNIÃO AFRICANA Addis Ababa, ETHIOPIA P. O. Box 3243 Telephone 517700 Cables: OAU, ADDIS ABABA EX/CL/34 (III) MECHANISM FOR FOLLOW-UP AND REPORTING ON THE IMPLEMENTATION OF
More informationPARTNERSHIP & SPONSORSHIP OPPORTUNITIES
PARTNERSHIP & SPONSORSHIP OPPORTUNITIES About MPI Meeting Professionals International (MPI) is the largest meeting and event industry association worldwide. Founded in 1972, the organization provides innovative
More informationREPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES
Information Brief: REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES Family Care International (FCI) developed this information brief as part of the Mobilising Advocates
More informationTHE FUND TO END VIOLENCE AGAINST CHILDREN Working toward a world in which every child grows up free from violence
THE FUND TO END VIOLENCE AGAINST CHILDREN Working toward a world in which every child grows up free from violence $ Contributed Awarded Co-funding leveraged $3 $29.4 $.9 PROJECTS 43 $24 Online violence
More informationSuccessful collaboration for research development between the NIH and patient organisations
Successful collaboration for research development between the NIH and patient organisations Stephen C. Groft, Pharm.D. Office of Rare Diseases s of Health Department of Health and Human Services EURORDIS
More informationEuropean Patients Academy on Therapeutic Innovation
European Patients Academy on Therapeutic Innovation http://www.patientsacademy.eu info@patientsacademy.eu The project is receiving support from the Innovative Medicines Initiative Joint Undertaking under
More informationEUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL
EUROPEAN GUIDE ON QUALITY IMPROVEMENT IN COMPREHENSIVE CANCER CONTROL Policy Paper on National Cancer Control Programmes (NCCPs)/ Cancer Documents in Europe Marjetka Jelenc, Tit Albreht, Karen Budewig,
More informationThe power of innovation to save lives
Innovative Finance The power of innovation to save lives May 2013 The challenge Life or death for a young child too often depends on whether he is born in a country where vaccines are available or not.
More informationConsumer Participation Strategy
Consumer Participation Strategy Plan Implementation Period 2011-2013 Date: 24 December 2010 Developed by: NEMICS Directorate in consultation with Acknowledgements and thank you to: s, Dr Ian Roos (Cancer
More informationSpinal Injuries Ireland. Research Results and Strategic Plan 2015, Fiona Bolger
Spinal Injuries Ireland Research Results and Strategic Plan 2015, Fiona Bolger Research with Members 385 one to one interviews with members completed 24% of SII popula>on. 27% female and 73 % male. Health
More informationContribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone
COMMUNICATIONS AND AWARENESS MANAGER OVARIAN CANCER AUSTRALIA Contribute to our vision of saving lives and ensuring no woman with ovarian cancer walks alone National role Location: Melbourne CBD Position
More informationFuture of diabetes research in the EU- the EC perspectives
Future of diabetes research in the EU- the EC perspectives Dr Karim Berkouk, Deputy Head of Unit DG for Health Directorate European Commission Overview Challenges in diabetes Research in diabetes at EU
More informationLessons learnt from cancer screening programmes as an example for establishing the Czech National Coordination Centre
Czech National Coordination Centre for Prevention of Serious Diseases CZ.03.2.63/0.0/0.0/15_039/0006904 Lessons learnt from cancer screening programmes as an example for establishing the Czech National
More informationTransplant Recipients International Organization, Inc. Strategic Plan. Board Approved September 28, 2012
Transplant Recipients International Organization, Inc. Strategic Plan Board Approved September 28, 2012 TRIO Mission TRIO is a non-profit international organization committed to improving the quality of
More informationWorkshop for OIE national Focal Points for Veterinary Products November 2010, Johannesburg, South Africa. Presentation
Dr. Anja Holm Chair of CVMP, EMA Danish Medicines Agency Copenhagen, DK - Denmark anh@dkma.dk Overview of existing structures relevant for Veterinary Products Regional Structures: Europe European Medicine
More information